Ramsey Quantitative Systems Buys New Stake in Nu Skin Enterprises, Inc. (NUS)

Ramsey Quantitative Systems bought a new position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 3,813 shares of the company’s stock, valued at approximately $260,000.

A number of other large investors also recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Nu Skin Enterprises by 38.6% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,082 shares of the company’s stock worth $210,000 after purchasing an additional 858 shares during the last quarter. Meeder Asset Management Inc. grew its position in Nu Skin Enterprises by 7.9% during the 4th quarter. Meeder Asset Management Inc. now owns 12,830 shares of the company’s stock worth $875,000 after purchasing an additional 939 shares during the last quarter. TD Asset Management Inc. grew its position in Nu Skin Enterprises by 5.1% during the 3rd quarter. TD Asset Management Inc. now owns 20,892 shares of the company’s stock worth $1,284,000 after purchasing an additional 1,020 shares during the last quarter. Bank of Montreal Can grew its position in Nu Skin Enterprises by 12.0% during the 4th quarter. Bank of Montreal Can now owns 9,680 shares of the company’s stock worth $660,000 after purchasing an additional 1,034 shares during the last quarter. Finally, Eagle Boston Investment Management Inc. grew its position in Nu Skin Enterprises by 1.3% during the 3rd quarter. Eagle Boston Investment Management Inc. now owns 110,923 shares of the company’s stock worth $6,698,000 after purchasing an additional 1,464 shares during the last quarter. 76.17% of the stock is currently owned by institutional investors.

Shares of Nu Skin Enterprises, Inc. (NYSE NUS) opened at $71.81 on Friday. The company has a market cap of $3,780.00, a price-to-earnings ratio of 22.30, a PEG ratio of 1.99 and a beta of 1.46. The company has a quick ratio of 1.17, a current ratio of 1.74 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises, Inc. has a twelve month low of $48.12 and a twelve month high of $74.45.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Thursday, February 15th. The company reported $1.20 EPS for the quarter, beating the consensus estimate of $1.19 by $0.01. The business had revenue of $666.20 million for the quarter, compared to the consensus estimate of $667.39 million. Nu Skin Enterprises had a net margin of 5.68% and a return on equity of 25.23%. The business’s revenue for the quarter was up 25.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.79 EPS. sell-side analysts predict that Nu Skin Enterprises, Inc. will post 3.56 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 14th. Stockholders of record on Monday, February 26th will be issued a $0.365 dividend. This is an increase from Nu Skin Enterprises’s previous quarterly dividend of $0.36. This represents a $1.46 annualized dividend and a dividend yield of 2.03%. The ex-dividend date of this dividend is Friday, February 23rd. Nu Skin Enterprises’s dividend payout ratio is 44.72%.

In other news, Chairman Steven Lund sold 108,132 shares of the company’s stock in a transaction on Friday, December 22nd. The shares were sold at an average price of $68.81, for a total value of $7,440,562.92. Following the sale, the chairman now directly owns 4,769 shares of the company’s stock, valued at approximately $328,154.89. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders sold a total of 195,978 shares of company stock worth $13,512,733 over the last ninety days. Insiders own 5.20% of the company’s stock.

Several research firms have weighed in on NUS. Pivotal Research reissued a “buy” rating and set a $90.00 target price on shares of Nu Skin Enterprises in a research report on Friday, February 16th. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Stifel Nicolaus boosted their target price on shares of Nu Skin Enterprises from $50.00 to $57.00 and gave the stock a “sell” rating in a research report on Friday, February 16th. Zacks Investment Research downgraded shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Wednesday, December 20th. Finally, Citigroup reaffirmed a “buy” rating and issued a $81.00 price objective (up from $70.00) on shares of Nu Skin Enterprises in a report on Tuesday, January 23rd. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $71.29.

TRADEMARK VIOLATION NOTICE: This story was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/24/ramsey-quantitative-systems-buys-new-stake-in-nu-skin-enterprises-inc-nus.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply